The popular new drug can bring dramatic weight loss for some patients. But for NZ, tackling a rising obesity epidemic is ...

First batch of obesity medication get government approval ...

Novo hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales, saying it now expects ...

The UAE has become the second country globally to approve the treatment, underscoring its leadership in adopting advanced ...

If you’re weighing the option of Wegovy versus Zepbound for weight loss, here’s how the two medications compare in terms of ...

The EMA’s CHMP delivered two positive opinions, which will likely see an expansion of Novo Nordisk’s Wegovy offerings in Europe.

A GLP-1 Bridge pilot program launching in July can significantly reduce the price you pay for weight loss meds. Here’s how to qualify.

The UAE has approved oral Wegovy (semaglutide) for long-term weight management, becoming the second country globally to ...

Oral Ozempic and Wegovy pills are now available for same-day delivery at Amazon. Novo Nordisk's CEO says more than 1 million ...

Novo Nordisk (NVO) stock is closing its gap with Eli Lilly (LLY) as the company's Wegovy pill outperforms Lilly's (LLY) Foundayo in its market launch. Read more here.

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy.

GoodRx reports Wegovy HD is a higher-dose version of Wegovy, offering potentially greater weight loss but with increased side ...